|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/00 | (2006.01) |
| A61K 38/15 | (2006.01) | ||
| A61K 9/20 | (2006.01) | ||
| A61K 9/19 | (2006.01) | ||
| A61K 47/26 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 2802340 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13701320.7 |
| Date of filing the European patent application | 2013-01-11 | |
| (97) | Date of publication of the European application | 2014-11-19 |
| (45) | Date of publication and mention of the grant of the patent | 2020-10-28 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2013/021212 |
| Date | 2013-01-11 |
| (87) | Number | WO 2013/106696 |
| Date | 2013-07-18 |
| (30) | Number | Date | Country code |
| 201261586066 P | 2012-01-12 | US |
| (72) |
HUANG, Lianfeng, US
HUI, Ho-wah, US
PEYKOV, Victor, US
FOSS, Willard, R., US
NARINGREKAR, Vijay, US
LAI, Mei, US
|
| (73) |
Celgene Corporation,
86 Morris Avenue, Summit, NJ 07901,
US
|
| (54) | ROMIDEPSIN FORMULATIONS AND USES THEREOF |
| ROMIDEPSIN FORMULATIONS AND USES THEREOF |